Evidence map›Paper›PMID 41206577›Full record

ArticleThe British journal of surgery2025

Nationwide outcomes of 1000 robotic pancreatoduodenectomies across the four phases of the learning curve.

Anouk M L H Emmen, Bram L J van den Broek, Tessa E Hendriks, Olivier R Busch, Bert A Bonsing, Marie L Cappelle, Peter-Paul L O Coene, Sebastiaan Festen, Erwin van der Harst, Ignace H J T de Hingh and 16 more

Abstract readMulticenter Study
In one paragraph

Article in The British journal of surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Anouk M L H EmmenDepartment of Surgery, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands.
Bram L J van den BroekDepartment of Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, The Netherlands.
Tessa E HendriksDepartment of Surgery, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands.ORCID 0009-0007-7418-3056
Olivier R BuschDepartment of Surgery, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0001-9605-6831
Bert A BonsingDepartment of Surgery, Leiden University Medical Centre, Leiden, The Netherlands.
Marie L CappelleDepartment of Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, The Netherlands.
Peter-Paul L O CoeneDepartment of Surgery, Maasstad Hospital, Rotterdam, The Netherlands.
Sebastiaan FestenDepartment of Surgery, OLVG, Amsterdam, The Netherlands.
Erwin van der HarstDepartment of Surgery, Maasstad Hospital, Rotterdam, The Netherlands.
Ignace H J T de HinghDepartment of Surgery, Catharina Hospital, Eindhoven, The Netherlands.ORCID 0000-0003-3491-4268
Cees J H M van LaarhovenDepartment of Surgery, Radboud UMC, Nijmegen, The Netherlands.
Daan J LipsDepartment of Surgery, Medisch Spectrum Twente, Enschede, The Netherlands.
Joost SprakelDepartment of Surgery, Medisch Spectrum Twente, Enschede, The Netherlands.
Misha D P LuyerDepartment of Surgery, Catharina Hospital, Eindhoven, The Netherlands.ORCID 0000-0002-9483-1520
J Sven D MieogDepartment of Surgery, Leiden University Medical Centre, Leiden, The Netherlands.ORCID 0000-0002-3649-8504
Hjalmar C van SantvoortDepartment of Surgery, Regional Academic Cancer Centre Utrecht, UMC Utrecht Cancer Centre & St Antonius, Utrecht, The Netherlands.
George van der SchellingDepartment of Surgery, Amphia Hospital, Breda, The Netherlands.
Jan H WijsmanDepartment of Surgery, Amphia Hospital, Breda, The Netherlands.
Gijs A PatijnDepartment of Surgery, Isala, Zwolle, The Netherlands.
Roeland F de WildeDepartment of Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, The Netherlands.
Maurice J W ZwartDepartment of Surgery, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands.
Wouter J M DerksenDepartment of Surgery, Regional Academic Cancer Centre Utrecht, UMC Utrecht Cancer Centre & St Antonius, Utrecht, The Netherlands.
I Quintus MolenaarDepartment of Surgery, Regional Academic Cancer Centre Utrecht, UMC Utrecht Cancer Centre & St Antonius, Utrecht, The Netherlands.
Bas Groot KoerkampDepartment of Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, The Netherlands.ORCID 0000-0003-1917-6973
Marc G BesselinkDepartment of Surgery, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0003-2650-9350
Members of the Dutch Institute for Clinical Auditing and the Dutch Pancreatic Cancer Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRobotic pancreatoduodenectomy (RPD) is increasingly being implemented to enhance patient recovery, but it is unclear what happens to patient outcomes after the initial learning curve. The aim of this study was to evaluate the first 1000 consecutive RPD performed in the Netherlands.

methodsA nationwide analysis of patients who underwent RPD in 13 centres (March 2016-August 2023) from the Dutch Pancreatic Cancer Audit was performed. Patients were grouped based on published learning curve cut-offs (phases 1-4): 1-15, 16-62, 63-84, and >84 RPD per centre respectively. Outcomes were compared between the four learning curve phases. Ideal Outcome rates were used to compare outcomes between centres.

resultsOverall, 1000 patients after RPD were included. The conversion rate was 10.1%, the rate of Clavien-Dindo complications of grade ≥III was 41.3%, the rate of postoperative pancreatic fistula of grade B/C was 24.4%, and the rate of in-hospital/30-day mortality was 3.9%. Of the patients, 71.1% had a high updated alternative fistula risk score. Improvements between the phases were found for five outcomes: median operating time (420, 360, 349, and 369 min respectively; P < 0.001), conversion rate (21.7%, 10.0%, 2.8%, and 7.5% respectively; P < 0.001), rate of delayed gastric emptying (DGE) of grade B/C (32.3%, 22.6%, 15.4%, and 20.2% respectively; P = 0.003), reoperation rate (9.9%, 11.3%, 9.8%, and 4.9% respectively; P = 0.026), and median duration of hospital stay (12, 11, 10, and 10 days respectively; P = 0.035). The rate of Clavien-Dindo complications of grade ≥III and the rate of in-hospital/30-day mortality remained stable. The Ideal Outcome rate (mean 47%) did not differ between centres.

conclusionAcross four learning curve phases in a nationwide cohort, improvements were observed for operating time, conversion rate, rate of DGE of grade B/C, reoperation rate, and duration of hospital stay.

Indexed as

Learning CurvePancreatic NeoplasmsPancreaticoduodenectomyRobotic Surgical ProceduresAdultAgedAged, 80 and overFemaleHumansLength of StayMaleMiddle AgedNetherlandsOperative TimePostoperative ComplicationsRetrospective Studies

Identifiers

PMID41206577
PMCPMC12596432

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.